Jarari Noah, Rao Narasinga, Peela Jagannadha Rao, Ellafi Khaled A, Shakila Srikumar, Said Abdul R, Nelapalli Nagaraja Kumari, Min Yupa, Tun Kin Darli, Jamallulail Syed Ibrahim, Rawal Avinash Kousik, Ramanujam Ranjani, Yedla Ramesh Naidu, Kandregula Dhilip Kumar, Argi Anuradha, Peela Laxmi Teja
Department of Pharmacology, University of Benghazi, Benghazi, Libya.
Department of Medicine, Andhra Medical College, Visakhapatnam, India.
Clin Hypertens. 2016 Mar 27;22:7. doi: 10.1186/s40885-016-0042-0. eCollection 2015.
Hypertension continues to be an important public health concern because of its associated morbidity, mortality and economic impact on the society. It is a significant risk factor for cardiovascular, cerebrovascular and renal complications. It has been estimated that by 2025, 1.56 billion individuals will have hypertension. The increasing prevalence of hypertension and the continually increasing expense of its treatment influence the prescribing patterns among physicians and compliance to the treatment by the patients. A number of national and international guidelines for the management of hypertension have been published. Since many years ago, diuretics were considered as the first-line drugs for treatment of hypertension therapy; however, the recent guidelines by the Joint National Commission (JNC8 guidelines) recommend both calcium channel blockers as well as angiotensin-converting enzyme inhibitors as first-line drugs, in addition to diuretics. Antihypertensive drug combinations are generally used for effective long-term management and to treat comorbid conditions. This review focuses on the antihypertensive medication utilization, their cost factors, adherence to treatment by patients, and physicians' adherence to guidelines in prescribing medications in different settings including Indian scenario. The antihypertensive medication prescribing pattern studies help in monitoring, evaluation and necessary modifications to the prescribing habits to achieve rational and cost-effective treatment. Additionally, periodic updating of recommended guidelines and innovative drug formulations, and prescription monitoring studies help in rational use of antihypertensive drugs, which can be tailored to suit the patients' requirements, including those in the developing countries.
高血压因其相关的发病率、死亡率以及对社会的经济影响,仍然是一个重要的公共卫生问题。它是心血管、脑血管和肾脏并发症的重要危险因素。据估计,到2025年,将有15.6亿人患有高血压。高血压患病率的上升及其治疗费用的持续增加影响着医生的处方模式以及患者对治疗的依从性。已经发布了许多国家和国际高血压管理指南。多年来,利尿剂一直被视为高血压治疗的一线药物;然而,美国国立综合癌症网络(JNC8指南)最近的指南除了推荐利尿剂外,还推荐钙通道阻滞剂和血管紧张素转换酶抑制剂作为一线药物。抗高血压药物联合使用通常用于有效的长期管理和治疗合并症。本综述重点关注抗高血压药物的使用情况、其成本因素、患者对治疗的依从性以及医生在包括印度在内的不同环境中开药时对指南的依从性。抗高血压药物处方模式研究有助于监测、评估和必要时修改处方习惯,以实现合理且具有成本效益的治疗。此外,定期更新推荐指南和创新药物配方以及处方监测研究有助于合理使用抗高血压药物,这可以根据患者的需求进行调整,包括发展中国家的患者。